Gilead Sciences, Inc. (Nasdaq: GILD) will present new data from the company’s broad lung cancer clinical development program ...

Very pleased to be hosting Gilead this afternoon, sorry. And we have joining us Dan O'Day, the company's Chairman and CEO; and Andy Dickinson, the company's CFO. Thank you both for taking time out of ...

Mohit Bansal, an analyst from Wells Fargo, maintained the Hold rating on Gilead Sciences (GILD – Research Report). The associated price ...

As we have mentioned in our article, “10 Best Penny Stocks to Buy Under $1," the size of the global biotechnology industry ...

Looking at River Valley's challenging non-league schedule, plus Rob McCurdy offers his picks for Friday night football games ...

An Ohio State Highway Patrol trooper cited a driver for going 101 mph in a posted 55 mph zone on Interstate 77 in Canton over ...

Here, Johanna Mercier, Chief Commercial Officer, shares how Gilead works to help remove barriers to care, improve health equity and increase access to life-changing therapies – all of which underscore ...

The SPDR S&P Biotech ETF XBI, the most popular product in the space, tracks an equal-weighted index and is therefore tilted towards smaller companies. The iShares Biotechnology ETF IBB tracks a market ...

Symbiotic Capital launches with $600 million-plus in capital, about half of which has been lent to advanced-stage life ...

A new study provides important insights into the pharmacokinetics and safety of intravenous remdesivir in treating the ...

Who are the best high school boys cross country runners in the Columbus area? Here's our list of athletes to watch for the ...

Daniel Geffken appointed Chief Financial Officer ad interimMike Campbell appointed Chief Commercial OfficerThree senior leaders appointed for ...